79.80
+1.79%
Close of 9 Nov 2026, in TWD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About DR.Wu Skincare Co
Its shares trade on Taipei Exchange under the ticker 6523.TWO. It has been listed since 30 April 2015. In the fiscal year to 31 December 2025, it reported revenue of TWD 1.17bn and net income of TWD 350.3m. At that date it held total assets of TWD 1.59bn and shareholders' equity of TWD 1.35bn.
DR.WU Skincare Co., Ltd. engages in the research, development, and sale of medical beauty care products. The company is headquartered in Taipei City, Taipei. The company went IPO on 2015-04-30. Its businesses include corporate management consulting, hospital management consulting, beauty salon, slimming beauty, nutrition consulting, electronic information providing, wholesale of cosmetics, intellectual property rights, international trading, among others. Its product lines include HYDRATING System, MANDELIC Renewal, AGEVERSAL, VITAMIN C+, MINERAL Makeup, among others.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Consumer Staples
- Industry
- Personal Care Products
- Listed since
- 30 Apr 2015
- Website
- drwu.com ↗
Leadership
Pay as last reported
- Mr. Yi-Ju WuChairman of the Board, Chief Executive Officer, Acting General Manager, since 2003
- Carol ChengChief Financial Officer, Head of Finance & Accounting, Corporate Governance Officer
- Yijun GuoDeputy General Manager, Director
- Mr. Tiger HsingDirector
- Mr. Ying-Chin WuDirector
- Mr. Chao-Sheng ChiangIndependent Director
- Mr. Yuan-Jen HsuIndependent Director
- Qingyi LiIndependent Director
- Huangyou LinIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- DR.WU Skincare Co Ltd's HYDRATING System targets medical beauty care with high demand in Taipei City.
- The company's MANDELIC Renewal product line serves the growing medical aesthetics segment in Taiwan.
- DR.WU's VITAMIN C+ product line addresses consumer demand for anti-aging solutions in the Consumer Staples sector.
Weaknesses
- DR.WU Skincare Co Ltd's business includes hospital management consulting, which is not core to skincare.
- The company's slimming beauty services face competition from established wellness providers in Taipei.
- DR.WU's electronic information providing business lacks focus on skincare innovation.
Opportunities
- Expanding the MINERAL Makeup product line into international markets could leverage Taiwan's cosmetic exports.
- The AGEVERSAL product line can capitalize on rising demand for anti-aging solutions in the Consumer Staples sector.
- DR.WU can grow its corporate management consulting services to support healthcare businesses in Taiwan.
Threats
- Competition from established skincare brands in the Consumer Staples sector poses a threat to DR.WU.
- The financial sector's volatility may impact DR.WU's international trading operations.
- Regulatory changes in Taiwan's cosmetic industry could affect DR.WU's product development.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.